Correlations Between Choroidal Thickness and Renal Function in Patients with Retinal Vein Occlusion

Overview

Journal Sci Rep

Specialty Science

Date 2020 Oct 9

PMID 33033387

Citations 2

Authors

Sang Uk Choi

Ja Young Oh

Jee Taek Kim

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to analyze the correlation of renal function indices with sub-foveal choroidal thickness (SFChT) in treatment-naïve (naïve) eyes with retinal vein occlusion (RVO) using swept-source optical coherence tomography (SS-OCT) and systemic workup. Retrospective chart review was performed from Dec 2016 to Sep 2019 in patients newly diagnosed with treatment-naïve unilateral RVO. Ocular parameters, including SFChT, and systemic profiles, including renal function indices, were reviewed. Simple and multiple linear regression analyses were performed to check if there was a correlation between renal profiles and SFChT. A total of 56 patients were included in the study; 34 of them were branch RVO and 22 were central RVO patients. Multiple linear regression analysis revealed that SFChT was positively correlated with estimated glomerular filtration rate (eGFR) (P < 0.001). SFChT showed significant correlation with renal function indices. In addition, choroidal thickness may be considered as systemic biomarkers for renal function.

Citing Articles

Choroidal vascularity index of patients with coronary artery disease.

Seo W, Yoo H, Kim Y, Park S, Kim Y Sci Rep. 2022; 12(1):3036.

PMID: 35194148 PMC: 8864027. DOI: 10.1038/s41598-022-07120-8.

Correlation of Renal Profiles with Choroidal Vascularity Index in Eyes with Diabetic Retinopathy.

Kim J, Lee I J Clin Med. 2021; 10(21).

PMID: 34768674 PMC: 8584344. DOI: 10.3390/jcm10215155.

References

Song P, Xu Y, Zha M, Zhang Y, Rudan I . Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019; 9(1):010427. PMC: 6513508. DOI: 10.7189/jogh.09.010427. View

Jonas J, Mones J, Glacet-Bernard A, Coscas G . Retinal Vein Occlusions. Dev Ophthalmol. 2017; 58:139-167. DOI: 10.1159/000455278. View

Wang S, Xu L, Jonas J, Wong T, Cui T, Li Y . Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye Study. Ophthalmology. 2009; 116(12):2373-80. DOI: 10.1016/j.ophtha.2009.05.041. View

Wong T, Larsen E, Klein R, Mitchell P, Couper D, Klein B . Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology. 2005; 112(4):540-7. DOI: 10.1016/j.ophtha.2004.10.039. View

Cugati S, Wang J, Knudtson M, Rochtchina E, Klein R, Klein B . Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology. 2006; 114(3):520-4. DOI: 10.1016/j.ophtha.2006.06.061. View

Mule G, Vadala M, Geraci G, Cottone S . Retinal vascular imaging in cardiovascular medicine: New tools for an old examination. Atherosclerosis. 2017; 268:188-190. DOI: 10.1016/j.atherosclerosis.2017.11.001. View

Du K, Xu L, Shao L, Chen C, Zhou J, Wang Y . Subfoveal choroidal thickness in retinal vein occlusion. Ophthalmology. 2013; 120(12):2749-2750. DOI: 10.1016/j.ophtha.2013.08.031. View

Tang F, Xu F, Zhong H, Zhao X, Lv M, Yang K . Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO. BMC Ophthalmol. 2019; 19(1):133. PMC: 6588881. DOI: 10.1186/s12886-019-1143-9. View

Balmforth C, van Bragt J, Ruijs T, Cameron J, Kimmitt R, Moorhouse R . Chorioretinal thinning in chronic kidney disease links to inflammation and endothelial dysfunction. JCI Insight. 2016; 1(20):e89173. PMC: 5135281. DOI: 10.1172/jci.insight.89173. View

10.

Vadala M, Castellucci M, Guarrasi G, Terrasi M, La Blasca T, Mule G . Retinal and choroidal vasculature changes associated with chronic kidney disease. Graefes Arch Clin Exp Ophthalmol. 2019; 257(8):1687-1698. DOI: 10.1007/s00417-019-04358-3. View

11.

Mule G, Vadala M, La Blasca T, Gaetani R, Virone G, Guarneri M . Association between early-stage chronic kidney disease and reduced choroidal thickness in essential hypertensive patients. Hypertens Res. 2019; 42(7):990-1000. DOI: 10.1038/s41440-018-0195-1. View

12.

Haroun M, Jaar B, Hoffman S, Comstock G, Klag M, Coresh J . Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003; 14(11):2934-41. DOI: 10.1097/01.asn.0000095249.99803.85. View

13.

Wong C, Wong T, Cheng C, Sabanayagam C . Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. Kidney Int. 2013; 85(6):1290-302. DOI: 10.1038/ki.2013.491. View

14.

Zhou J, Xu L, Wang S, Wang Y, You Q, Tu Y . The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study. Ophthalmology. 2013; 120(4):803-8. DOI: 10.1016/j.ophtha.2012.09.033. View

15.

Cugati S, Wang J, Rochtchina E, Mitchell P . Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol. 2006; 124(5):726-32. DOI: 10.1001/archopht.124.5.726. View

16.

Ponto K, Elbaz H, Peto T, Laubert-Reh D, Binder H, Wild P . Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study. J Thromb Haemost. 2015; 13(7):1254-63. DOI: 10.1111/jth.12982. View

17.

Breyer M, Susztak K . The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov. 2016; 15(8):568-88. PMC: 5511522. DOI: 10.1038/nrd.2016.67. View

18.

Izzedine H, Bodaghi B, Launay-Vacher V, Deray G . Eye and kidney: from clinical findings to genetic explanations. J Am Soc Nephrol. 2003; 14(2):516-29. DOI: 10.1097/01.asn.0000051705.97966.ad. View

19.

Zipfel P, Heinen S, Jozsi M, Skerka C . Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol Immunol. 2005; 43(1-2):97-106. DOI: 10.1016/j.molimm.2005.06.015. View

20.

Wilkinson-Berka J, Agrotis A, Deliyanti D . The retinal renin-angiotensin system: roles of angiotensin II and aldosterone. Peptides. 2012; 36(1):142-50. DOI: 10.1016/j.peptides.2012.04.008. View